DEXTROSE SODIUM CHLORIDE 0.9% PNSS 100ML NIRLIFE

0.9% Sodium Chloride Injection, USP is sterile and nonpyrogenic. It is a parenteral solution containing sodium chloride in water for injection intended for intravenous administration. Each 100 mL of 0.9% Sodium Chloride Injection, USP contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium (Na+ ) 154 mEq; chloride (Cl– ) 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH is 5.6 (4.5 to 7.0). This solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only as a single-dose injection. When smaller doses are required, the unused portion should be discarded. 0.9% Sodium Chloride Injection, USP is a parenteral fluid and electrolyte replenisher. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a clear multilayer polyolefin plastic film. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.

INDICATIONS AND USAGE: Intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient.

PRECAUTIONS: Plastic containers should not be used in series connections. Because residual air is drawn from the primary container before the fluid from the secondary container is administered, this use could result in an air embolism. If the residual air in the container is not fully evacuated prior to administration, pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in air embolism. Air embolism could occur if a vented intravenous administration set is used with the vent in the open position. Flexible plastic containers should not be used with vented intravenous administration sets with the vent open.

DOSAGE AND ADMINISTRATION: The dose is determined by the patient’s age, weight, and clinical condition. It’s possible that some additives are incompatible. If a pharmacist is available, speak with him or her. Use aseptic technique when adding additives, thoroughly mix them in, and don’t store them. When the solution and container allow, parenteral drug products should be visually inspected for particulate matter and discoloration prior to administration. Administration Preparation: (Use aseptic technique)

NOTE: See appropriate IV administration set